{"name":"Adrenas Therapeutics Inc","slug":"adrenas-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AAV BBP-631","genericName":"AAV BBP-631","slug":"aav-bbp-631","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AAV BBP-631","genericName":"AAV BBP-631","slug":"aav-bbp-631","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQS2E0RVh5TDRmVEV5WUVDUkRGS3BjZ09ZWFhCYmNvaThaNGx3RXE3ektZVmtMWWd3ZUMyaGpEZkN0YzZZT3NHVjhKdGZYSERfWlZOdlpTNW1hRlBEU3l0ZEdZV0VXMTNEZG1BeHY3V1Y1S3BJUDV6bHMyNzRENXVvSDc1UWE2VlJyNVJuRVB2Y2VZOHVJUGV0allSd1M?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Adeno-Associated Viral Vectors Market - openPR.com","headline":"Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Adeno-Associated Viral Vectors Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOdlp1MHdjNG5sd19uRWtKSnVqVjlGODRhNU1sS1J0eTBFVXllYzdsUE9OWTRXaWZRQkMxRVZxRm9JX05ZT0RKcFp0UzdPSktJU0J2NjVRdTBabUo3SDRTOHdMMmpTTUlTenZ5b3pRcUtmMnpyTTFGR1BBR3ZTaWpVV0hoV0EwSEVpSk00anM3bnJKc00?oc=5","date":"2025-08-08","type":"pipeline","source":"MedPage Today","summary":"Classic Congenital Adrenal Hyperplasia: Understanding Treatment Options - MedPage Today","headline":"Classic Congenital Adrenal Hyperplasia: Understanding Treatment Options","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOVjBZZUVZOTd6eTBWUFlzV0tlRGYzZC1ZTmd4QU5yajh2aTc1Qi1tbW5SQWdJV3FNajlxNEh1VkZITUplRjNoWGFRN0Q2blZHc2Q5MUE1anVZY0ZpTXV6R1dxT0Q5OF9QWHNOVGE0d0l0cVNFaHZVY3o1VTVRUkFXVW8yY2liRWFCbVltRHFIbTlPS21kb3ZSRkFvMU1hMjhUMzVXUWVzTWNMZlpQV251RVRqb2plUTZoMnRzbFpKQXY1cDF4NjFReElOa0lsal9TdDNIdkZBZw?oc=5","date":"2025-04-18","type":"pipeline","source":"Healio","summary":"After decades with only one option, new therapies emerge for congenital adrenal hyperplasia - Healio","headline":"After decades with only one option, new therapies emerge for congenital adrenal hyperplasia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOSE1nX1VRVlFZTmdXcDBuazB2Nkdxa09aY092cFhMazhtTERMbDdBYmNOcmxXMXhuTFptdDBnTTJLeGpFUFFxdEZjMnNIUFhVa0VKbXp3RlFKSTZMbnNSazlJUHAxZWJIS0FqUXNfV0toQVBBa0hnb3RkbUxsWlZYWkVZYzl0LUFSck5RR0NSekFITG41M0Uxb2NyV3MwVUFRNlFxb2dzNE13RzJBcDBzYmJ6cDlhMkoyaURSWnBKbFQ1RFFiejN2VllsU0M?oc=5","date":"2025-01-03","type":"pipeline","source":"Healio","summary":"Relacorilant improves cardiometabolic metrics for patients with Cushing’s syndrome - Healio","headline":"Relacorilant improves cardiometabolic metrics for patients with Cushing’s syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQNDZsYkRna29LWHlPdERaSkpoYTZLWmlQbmVSRlJBVEFqVENiRWl5Q0E0MVhkMTY3VnhwUDlmcWZsdnQwVFA5SzJwSWw1dC0yeHgxbXFwa0dkOEFpb0ZGS3Rham5GaG1tcm1fX2YweHZfQnk2akhWa3ZQQzRSMm5RcTROdF8xUmV4a0lPRzlCaTlfZlE?oc=5","date":"2024-08-21","type":"pipeline","source":"BioPharma Dive","summary":"BridgeBio sends rare disease drugs to new company - BioPharma Dive","headline":"BridgeBio sends rare disease drugs to new company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQdEdrb21wbjlVc3pvYTFqbU15ZE5INWJITGJKR1FaWU4yQl91VEN4UFJHanhxT3ZzcmFuZi1RTllxSnFUZDJ5REVMRW1Ydnd2MDQ4cldlcjFOd1BIYzFqYnpzM0FHNmNhbU55a2lwRTdUZVVEajhfRHNrUzdXY1BGV2tFOXpnMVF5Ym8xMjVCQThrOUlqenBkX2ppVEIzbzJVMTBjNFpwaWNSOTJsZW9NbU53MWdSM1hfMm9PbGw1ZVFjaWdrSUtkMEM0N1AxNDdDYXJRVE5jbDZHcUN0RlNUbQ?oc=5","date":"2024-06-12","type":"pipeline","source":"PR Newswire UK","summary":"Adrenocortical Carcinoma Market to Exhibit Growth at a CAGR of 11.1% by 2034 | DelveInsight - PR Newswire UK","headline":"Adrenocortical Carcinoma Market to Exhibit Growth at a CAGR of 11.1% by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPLTBPQ2wwRm53MVk5elFDdGZxT0F4YW8wWmdpTnRoQjhvOFVka1p4eHFITEk1M1pycDdhQzZQa0xlVjZ4MzJGVjBjYzl0U3o5QnA1bFJOTmFhVUR4dk9QRHJsUkVjakRTbXlPYnJ6R3JsNVFZWFo0Z3pMdVZxcUFXVV96SFRPNk1GaUk4QVdsT0t3Nm5LcmhmZjVIVXV3MDVzSy1ZcXJDVmk?oc=5","date":"2020-10-05","type":"pipeline","source":"BioPharma Dive","summary":"With a sweetened offer, BridgeBio plans to reel in a subsidiary - BioPharma Dive","headline":"With a sweetened offer, BridgeBio plans to reel in a subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxOczFxRDhKeXk3RVhzWHlSZ215bVg2QUtLX3REa2FaMHZMTWU3ai1nNU9PYmN6Q1lCQUJtbllWdFdqVlpqNjBmenNEZ0J2Sklaa1loTWdNTHF6QmJ4OHpRN1hsNE44LTUxNnA1c2JqUnJ3OEhTVTZybjhZS0o3YmpRQ3hpQU9ucEExVDh5TDVIbmtNQ2NGSHpTYmc3QmZHb2lWZ2pvRm05ZDRhZ281cHBmQ0lUWm5xZ3NQMFN4WkU2UUN0VzRMbEFrb3Nvc2tDU3YyLWY5Y1BIN1FzajFUWlpDYmpOdFRwV1otbzFIcjc0Y0M3NjI3bWtQcVprcW9VVUdkaHVwSjNjV0F6OHBadDVraVdmc1FILUxuakwxSWxZMkZxU1N0QlFjSWJiYXFrRnFYbG5PNU9zVWdlcmY1NUJVVXByV0JtWDU0Xy00?oc=5","date":"2019-10-22","type":"trial","source":"prnewswire.com","summary":"BridgeBio Pharma Gene Therapy Subsidiaries Present Data Demonstrating Potential in Two Rare Disease Indications at the European Society of Gene and Cell Therapy Conference - prnewswire.com","headline":"BridgeBio Pharma Gene Therapy Subsidiaries Present Data Demonstrating Potential in Two Rare Disease Indications at the E","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}